Profil
Sean Nolan worked as a General Manager at Microsoft Corp.
from 2006 to 2014.
Prior to that, he was the Chief Technology Officer at drugstore.com, Inc. from 2000 to 2002.
He also worked as the Chief Architect at WebRelevance, Inc. Additionally, he served as the Chief Technical Officer at Adaptive Biotechnologies Corp.
from 2014 to 2020.
Mr. Nolan completed his undergraduate degree from Dartmouth College.
Anciens postes connus de Sean Nolan
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur Technique/Scientifique/R&D | 09/04/2020 |
| MICROSOFT CORPORATION | Corporate Officer/Principal | 01/05/2014 |
drugstore.com, Inc.
drugstore.com, Inc. Internet Software/ServicesTechnology Services Operates an online drugstore which offers health, beauty, wellness, personal care and pharmacy products | Directeur Technique/Scientifique/R&D | 01/01/2002 |
WebRelevance, Inc.
WebRelevance, Inc. Packaged SoftwareTechnology Services Designs, develops, and markets systems and application software | Corporate Officer/Principal | - |
Formation de Sean Nolan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Microsoft Corp.
Microsoft Corp. Packaged SoftwareTechnology Services Develops, manufactures and distributes software products | Technology Services |
drugstore.com, Inc.
drugstore.com, Inc. Internet Software/ServicesTechnology Services Operates an online drugstore which offers health, beauty, wellness, personal care and pharmacy products | Technology Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WebRelevance, Inc.
WebRelevance, Inc. Packaged SoftwareTechnology Services Designs, develops, and markets systems and application software | Technology Services |
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
















